FDA Issues Class II Risk Warning for Ritz Peanut Butter Crackers Due to Mislabeling That Could Trigger Life-Threatening Allergic Reactions
核心洞察
Mondelēz Global LLC (搜索) recalled over 76,000 cases of Ritz peanut butter cracker sandwiches (搜索) nationwide after discovering individual packages may be mislabeled as cheese instead of peanut butter due to supplier packaging defects.
The FDA issued a Class II risk warning on July 22, indicating the mislabeled products pose moderate public health risk and could cause serious or life-threatening allergic reactions in people with peanut allergies.
No injuries or illnesses have been reported to date, but peanut allergy (搜索) is the most common cause of life-threatening anaphylaxis (搜索) due to food according to the Mayo Clinic.
Mondelēz Global LLC (搜索) has issued a nationwide recall of over 76,000 cases of Ritz peanut butter cracker sandwiches (搜索) after discovering that individual packages may be mislabeled as cheese sandwiches instead of peanut butter ones. The U.S. Food and Drug Administration (FDA) escalated the safety concern by issuing a Class II risk warning on July 22, 2025, indicating that consuming the affected products poses a moderate risk to public health.
The labeling error stems from defective film packaging rolls used to wrap individual peanut butter products, which the company attributed to a supplier error. While the outer cartons were correctly labeled and indicated the presence of peanuts, the individual wrapper mislabeling creates a dangerous situation for consumers with peanut allergies who might unknowingly consume the product thinking it contains cheese.
Serious Health Risks for Allergic Consumers
People with peanut allergies face potentially severe consequences from consuming these mislabeled products. According to Mondelēz Global LLC (搜索), individuals with an allergy or severe sensitivity to peanuts "may risk serious or life-threatening allergic reactions by consuming this product."
Allergic reactions to peanuts can range from mild symptoms such as hives and lip swelling to life-threatening anaphylaxis (搜索). The Mayo Clinic identifies peanut allergy (搜索) as the most common cause of life-threatening anaphylaxis due to food, underscoring the severity of this recall situation.
Affected Products and Distribution
The recall encompasses four distinct product lines distributed to retail stores nationwide:
- Ritz Peanut Butter Cracker Sandwiches eight-pack: 37,985 cases with UPC 0 44000 88210 5 and best-by dates of November 1-9, 2025
- Ritz Peanut Butter Cracker Sandwiches 20-pack: 24,446 cases with UPC 0 44000 07584 2 and best-by dates of November 1-9, 2025, or January 2-22, 2026
- Ritz Peanut Butter Cracker Sandwiches 40-pack: 224 cases with UPC 0 44000 07819 5 and best-by dates of November 1-9, 2025, or January 2-22, 2026
- Ritz Filled Cracker Sandwich 20-count variety pack: 13,872 cases with UPC 0 44000 08095 2 and best-by dates of November 2-9, 2025
Company Response and Safety Measures
Mondelēz Global LLC (搜索) of East Hanover, New Jersey, announced the voluntary recall on July 8, 2025, as a precautionary measure. The company emphasized that no reports of injury or illness associated with consuming the affected cracker sandwiches have been reported to date.
The manufacturer has implemented corrective actions to prevent recurrence of this packaging issue. Consumers who purchased the affected products and have a peanut allergy (搜索) are advised not to consume them and can contact the company at 844-366-1171 with questions.
The FDA noted in its safety notice that other Ritz products, including different cracker types or items from Mondelēz Global LLC (搜索), are not affected by this recall. Consumers with peanut allergies should dispose of the recalled products rather than consume them, even if individual packages appear to be cheese-flavored.